Scientists at Northwestern University and University of California, Santa Barbara have created the first synthetic fragment of tau protein that acts like a prion.

A breakthrough CRISPR therapy, VERVE-102, shows promise for lifelong cholesterol control with a single dose, achieving up to ...

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...

Researchers at the Francis Crick Institute have shown that the Cryptosporidium parasite exports a protein into infected ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

The blood-brain barrier border protects the brain by regulating the flow of molecules, peptides, and cells, but it also keeps ...

Caribou is enrolling a 20-patient confirmatory cohort using the company’s HLA matching strategy in the ANTLER Phase 1 clinical trial in second-line large B cell lymphoma (2L LBCL). In H2 2025, Caribou ...

Dr. Gabor Balazsi, a Henry Laufer Professor of Physical and Quantitative Biology in the Laufer Center at Stony Brook ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

EditCo Bio has entered a strategic licensing agreement with Promega, securing access to the latter’s protein-tagging and ...